Berlin-Brandenburg Pregnancy Cohort
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18-45
SponsorCharite University, Berlin, Germany
About this trial
This study will investigate the interplay of different immune cells and placental cells as well as their potential for the development of pregnancy complications. In particular, the translation of the uteroplacental syndrome into a maternal syndrome, considered in the multifactorial pregnancy disorder preeclampsia, will be investigated. Immune cell subtypes are causally involved in the formation and translation of preeclampsia by inducing an endothelial dysfunction which leads to cardiovascular damage.
Eligibility criteria
Qualifiers
healthy pregnant women after giving informed consent
pregnant with diagnosis of preeclampsia, gestational hypertension or gestational diabetes
Disqualifiers
infections
alcohol and drug abuse
manifest and chronic diseases
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
Source ClinicalTrials.gov